NCT02222545 - Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 2, 2014

Primary Completion Date

January 30, 2020

Study Completion Date

August 11, 2020

Conditions

Thrombotic Microangiopathies

Interventions

BIOLOGICAL

OMS721

Trial Locations (24)

Omeros Investigational Site, New York

Omeros Investigational Site, Durham

Omeros Investigational Site, Madison

Omeros Investigational Site, Rochester

Omeros Investigational Site, Duarte

Omeros Investigational Site, Brussels

Omeros Investigational Site, Leuven

Omeros Investigational Site, Liège

Omeros Investigational Site, Sofia

Omeros Investigational Site, Shatin

Omeros Investigational Site, Bergamo

Omeros Investigational Site, Vilnius

Omeros Investigational Site, Selangan

Omeros Investigational Site, Christchurch

Omeros Investigational Site, Katowice

Omeros Investigational Site, Krakow

Omeros Investigational Site, Lodz

Omeros Investigational Site, Warsaw

Omeros Investigational Site, Singapore

Omeros Investigational Site, Taichung

Omeros Investigational Site, Taipei

Omeros Investigational Site, Ban Pathumwan

Omeros Investigational Site, Bangkok

Omeros Investigational Site, Pathum Thani